BamSEC and AlphaSense Join Forces
Learn More

Ironwood Pharmaceuticals Inc.

NASDAQ: IRWD    
Share price (1/7/25): $4.53    
Market cap (1/7/25): $725 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from S-3ASR 41 pages Ironwood Pharmaceuticals, Inc. and [ ], as Trustee Indenture Dated as of [ ], [ ]
12/34/56
EX-4.5
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-3ASR 53 pages Ironwood Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of [ ], [ ]
12/34/56
EX-4.5
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 77 pages Ironwood Pharmaceuticals, Inc. 1.50% Convertible Senior Notes Due 2026 Indenture Dated as of August 12, 2019 U.S. Bank National Association, as Trustee
12/34/56
EX-4.1
from 8-K 77 pages Ironwood Pharmaceuticals, Inc. 0.75% Convertible Senior Notes Due 2024 Indenture Dated as of August 12, 2019 U.S. Bank National Association, as Trustee
12/34/56
EX-4.1
from 8-K 4 pages Supplemental Indenture
12/34/56
EX-4.1
from 8-K 143 pages Indenture Dated as of September 23, 2016 by and Between Ironwood Pharmaceuticals, Inc., a Delaware Corporation, as Issuer of the Notes Described Herein, and U.S. Bank National Association, a National Banking Association, as Initial Trustee of the Notes Described Herein and as Operating Bank
12/34/56
EX-4.1
from 8-K 77 pages Ironwood Pharmaceuticals, Inc. 2.25% Convertible Senior Notes Due 2022 Indenture Dated as of June 15, 2015 U.S. Bank National Association, as Trustee
12/34/56
EX-4.1
from 8-K 109 pages Indenture Dated as of January 4, 2013 by and Between Ironwood Pharmaceuticals, Inc., a Delaware Corporation, as Issuer of the Notes Described Herein, and U.S. Bank National Association, a National Banking Association, as Initial Trustee of the Notes Described Herein and as Operating Bank
12/34/56
EX-4.1
from S-8 20 pages Ironwood Pharmaceuticals, Inc. Amended and Restated 2010 Employee, Director and Consultant Equity Incentive Plan
12/34/56
EX-4.1
from S-8 9 pages Ironwood Pharmaceuticals, Inc. 2010 Employee Stock Purchase Plan
12/34/56
EX-4.1
from S-1/A 2 pages Number Shares Specimen Specimen Ironwood Pharmaceuticals, Inc. Class a Common Stock $.001 Par Value Per Share See Reverse Side for Restrictions on Transfer
12/34/56
EX-4.2
from S-1 41 pages Eighth Amended and Restated Investors’ Rights Agreement by and Among Ironwood Pharmaceuticals, Inc., the Founders And
12/34/56